Technical Analysis for OPGN - OpGen, Inc.

Grade Last Price % Change Price Change
grade F 1.23 -6.82% -0.09
OPGN closed down 6.82 percent on Tuesday, November 12, 2019, on 1.32 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical OPGN trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
1,2,3 Retracement Bearish Bearish Swing Setup -6.82%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -6.82%
Pocket Pivot Bullish Swing Setup -6.82%

Older signals for OPGN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
OpGen, Inc. operates as an early commercial stage company using molecular testing and bioinformatics to assist healthcare providers to combat multi-drug-resistant bacterial infections. It offers Acuitas multi-drug-resistant organisms (MDRO) gene test, a molecular screening tool that detects 10 critical MDRO genes from 1 patient swab. The company also provides Acuitas CR Elite Test, which adds the ability to procure a standard microbiological culture result that provides additional information about the identified MDRO gene and its antibiotic susceptibility profile. In addition, it develops Acuitas Lighthouse MDRO bioinformatics product, which focuses on providing MDRO molecular information about an individual patient's resistance profile. OpGen, Inc. has a strategic collaboration with Hitachi High-Technologies Corporation to commercialize its genome mapping technology for mapping, assembly, and analysis of human DNA. The company was incorporated in 2001 and is headquartered in Gaithersburg, Maryland.
Health Healthcare Providers Pharmaceuticals Policy Antibiotic Antimicrobial Resistance Bacteria Veterinary Medicine Bioinformatics Evolutionary Biology Multi Drug Resistant Bacterial Infections
Is OPGN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 40.6
52 Week Low 1.15
Average Volume 705,174
200-Day Moving Average 11.1043
50-Day Moving Average 5.2518
20-Day Moving Average 2.6665
10-Day Moving Average 1.312
Average True Range 0.553
ADX 35.4
+DI 17.0118
-DI 31.1486
Chandelier Exit (Long, 3 ATRs ) 6.671
Chandelier Exit (Short, 3 ATRs ) 2.809
Upper Bollinger Band 6.7131
Lower Bollinger Band -1.3801
Percent B (%b) 0.32
BandWidth 303.51397
MACD Line -1.2801
MACD Signal Line -1.3031
MACD Histogram 0.023
Fundamentals Value
Market Cap 63.41 Million
Num Shares 51.6 Million
EPS -0.77
Price-to-Earnings (P/E) Ratio -1.60
Price-to-Sales 5.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.59
Resistance 3 (R3) 1.62 1.54 1.53
Resistance 2 (R2) 1.54 1.44 1.52 1.51
Resistance 1 (R1) 1.38 1.39 1.34 1.35 1.49
Pivot Point 1.30 1.30 1.28 1.28 1.30
Support 1 (S1) 1.14 1.20 1.10 1.11 0.97
Support 2 (S2) 1.06 1.15 1.04 0.95
Support 3 (S3) 0.90 1.06 0.93
Support 4 (S4) 0.87